Biotech gets back on track in November

December 01, 2009

› Learn more

Biotech takes it on the chin in October

November 02, 2009

› Learn more

Burrill & Company and WR Hambrecht + Co to collaborate on OpenIPO® transactions

Joint venture will focus on select healthcare companies

October 09, 2009

› Learn more

Biotech gets on a roll in third quarter

October 01, 2009

› Learn more

FDA Commissioner Dr. Margaret Hamburg headlines at the Burrill Annual Personalized Medicine Meeting

September 16, 2009

› Learn more

Biotech cools off in August but capital markets remain positive

September 01, 2009

› Learn more

Biotech hot in July driven by positive drug data and acquisitions

August 03, 2009

› Learn more

NewBridge Pharmaceuticals Announces Licensing of Pylera® for Middle East, Africa, Turkey & Caspian Region

July 22, 2009

› Learn more

Burrill Merchant Banking Advises Pfizer Inc. on Dermatology Portfolio Divestment

July 16, 2009

› Learn more

Burrill & Company invests in Taiwan Liposome Company

July 07, 2009

› Learn more

Biotech buoyed by strong capital market performance in second quarter

July 01, 2009

› Learn more

Shawn Cross Joins Burrill Merchant Banking

June 16, 2009

› Learn more

Biotech shows glimmer of an upward trend

June 01, 2009

› Learn more

Biotech drops on weaker first quarter drug sales, but broader markets remain on a roll

May 01, 2009

› Learn more

Burrill & Company announces promotions

April 10, 2009

› Learn more

Biotech finishes down after turbulent quarter

April 01, 2009

› Learn more

Burrill Merchant Banking Advises Adlyfe on Alzheimer’s Biomarker Partnership with Wyeth

March 17, 2009

› Learn more

Elk Run Developers Announce Partnership With Leading Life Sciences Firm

March 12, 2009

› Learn more

R&D Spending by U.S. Biopharmaceutical Companies increases 3 percent in 2008

March 10, 2009

› Learn more

Biotech takes a hit following the Administration’s budget plans for healthcare

March 02, 2009

› Learn more

Biotech Industry Turns a Profit for the First Time, But Milestone Overshadowed as Companies Struggle for Survival, Report Finds

February 25, 2009

› Learn more

Biotech holds steady as broader markets tumble

February 02, 2009

› Learn more

Biotech holds up well in the face of financial crisis and market turmoil

January 02, 2009

› Learn more

G. Steven Burrill predicts what’s ahead for biotech in 2009

January 02, 2009

› Learn more